Safety Study of MT-4666 in Subjects With Alzheimer's Disease
Clinical trial NCT02327182 · TERMINATED
Trial details
- NCT number
- NCT02327182
- Sponsor
- Tanabe Pharma Corporation
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2015-09-01
- Enrollment
- 117
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.